Novoheart Provides Corporate Update
VANCOUVER, British Columbia, Jan. 07, 2019 (GLOBE NEWSWIRE) — Novoheart Holdings Inc. (“Novoheart” or the “Company”) (TSXV: NVH; FWB: 3NH) […]
Questor Technology Inc. Announces $5.8 MM Clean Combustion to Power Project Award
CALGARY, Alberta, Jan. 07, 2019 (GLOBE NEWSWIRE) — Questor Technology Inc. (“Questor” or the “Company”) (TSX-V: QST) is pleased to […]
Rupert Resources Reports Results for Third Quarter 2018
TORONTO, Jan. 07, 2019 (GLOBE NEWSWIRE) — Rupert Resources Ltd (“Rupert” or the “Company”) (TSX-V:RUP) (FSE:R05) announces that it has today […]
Leading Blue Cross Blue Shield Organization Joins Growing Ranks of Health Plans To Leverage Inovalon’s Clinical Data Extraction as a Service and Natural Language Processing as a Service Solutions
Strong Demand for Capabilities with 14 Health Plan Engagements Executed Over the Past 10 Weeks BOWIE, Md., Jan. 07, 2019 […]
Dr. Isaac Kohane Joins Inovalon Board of Directors
Industry Leader in Healthcare Big Data, Machine Learning and Artificial Intelligence Joins Company’s Board of Directors BOWIE, Md., Jan. 07, […]
TSX News -
Goodfood to Report First Quarter Fiscal Year 2019 Results & Hold Annual General Meeting
MONTREAL, Jan. 07, 2019 (GLOBE NEWSWIRE) — Goodfood Market Corp. (“Goodfood” or “the Company”) (TSX: FOOD) will release its financial […]
MYnd Analytics and Emmaus Life Sciences Announce Merger and Spin-off Transaction
Emmaus’ commercial lead product Endari™ (L-glutamine oral powder) is FDA approved to reduce the acute complications of sickle cell disease […]
Spero Therapeutics Announces Positive Feedback from FDA Pre-Phase 3 Meeting for Oral SPR994 and Submission of IND for SPR994 in cUTI
FDA meeting supports single pivotal Phase 3 clinical trial of SPR994 in cUTI SPR994 IND submitted and ADAPT-PO Phase 3 […]
Dose Escalation in Liver Cancer Study with ADP-A2AFP (AFP) SPEAR T-cells and Moving to Expansion Phase in ADP-A2M10 (MAGE-A10) Lung Cancer Study after Favorable Safety Reviews
PHILADELPHIA and OXFORD, United Kingdom, Jan. 07, 2019 (GLOBE NEWSWIRE) — Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy […]
MacroGenics to Present at the 37th Annual J.P. Morgan Healthcare Conference
Rockville, MD, Jan. 07, 2019 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and […]
